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Phylogenetic analysisRecombination plays an important role in the evolutionary history of Hepatitis B virus (HBV). We performed
a phylogenetic analysis of 3403 full-length HBV genome sequences isolated from humans to deﬁne the geno-
type. The genome sequences were divided into 13 sub-datasets, each approximately 250 bp in length. Geno-
type designations obtained from the sub-datasets that differed from the genotype deﬁned by the whole
genome were assigned as putative recombinants. Our results showed that 3379 out of 3403 sequences
belonged to the previously described and putative genotypes A to J respectively, with 315 sequences deﬁned
in this analysis. The remaining 24 viruses had sequence divergence of less than 8% with both genotypes B and
C and were provisionally assigned genotype “BC”. 1047 out of 3403 sequences were identiﬁed to be putative
recombinants, of which 72 were identiﬁed to be novel recombinants. Notably, all viruses of the herein de-
scribed genotype “BC” were identiﬁed to be B/C recombinants.
© 2012 Elsevier Inc. All rights reserved.Introduction
Worldwide infection with Hepatitis B virus (HBV) poses a serious
threat to public health. HBV is estimated to have chronically infected
more than 350 million people worldwide and annually 600,000 die
from HBV-related liver diseases, principally cirrhosis and hepatocel-
lular carcinoma (Lee, 1997).
HBV belongs to the family Hepadnaviridae, with a circular, partial-
ly double-stranded DNA genome of approximately 3200 bp in length
(Kramvis et al., 2005). Based on sequence divergence over the entire
genome, eight genotypes (A–H) have been proposed and widely ac-
cepted (Kramvis et al., 2005). In 2008, a new genotype, I, was pro-
posed from HBV strains from Vietnam (Huy et al., 2008) and Laos
(Olinger et al., 2008a). However, the designation of genotype I was
not universally accepted as it did not diverge from genotype C by >8%
(Kurbanov et al., 2008). Recently, a strain isolated from a Japanese
male was assigned to genotype J, which was closely related to strains
isolated fromgibbon and orangutan (Tatematsu et al., 2009). HBV geno-
types have distinct geographical distributions with genotypes A and Dndation Ireland (PI grant 07/
ata collection and analysis, de-
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rights reserved.widely spread, genotypes B and C more prevalent in Asia, genotypes E
and F predominately in Africa and South America respectively and geno-
type H in central and southern regions of the United States (Kramvis
et al., 2005; Miyakawa and Mizokami, 2003).
Many recombination events between different HBV genotypes have
been described previously (Kramvis et al., 2005; Miyakawa and
Mizokami, 2003; Simmonds and Midgley, 2005; Yang et al., 2006; Ye
et al., 2010). For example, B/C recombinants are prevalent in Southeast
Asia and East Asia, but not in Japan (Sugauchi et al., 2002). Other inter-
genotypic recombinants, such as A/D (Owiredu et al., 2001), A/E
(Kurbanov et al., 2005), C/D (Cui et al., 2002; Wang et al., 2005) and
G/C (Suwannakarn et al., 2005), have also been identiﬁed in different
geographical regions. In fact, the generation of the proposed “genotype
I” was also associated with a triple recombination event among geno-
types A, C and G (Huy et al., 2008).
In particular, three large-scale recombination analyses aiming at a
comprehensive and systematic understanding of the role of recombina-
tion in the evolution of HBV have been performed, with each analyzing
a few hundred HBV genome sequences (Simmonds andMidgley, 2005;
Yang et al., 2006; Ye et al., 2010). With these large-scale analyses, many
novel HBV recombinants were identiﬁed, some of which represented
new inter-genotype recombination types with different breakpoints.
However, some of the sequences have been repeatedly analyzed in
these studies and they did not cover the majority of the sequences cur-
rently available in public databases.
In this study, we performed a recombination analysis of approxi-
mately 3300 HBV genome sequences available in GenBank using
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sive recombination analysis of HBV to date. From this work, 72 se-
quences were identiﬁed to be novel recombinants, of which 63
sequences represented 31 novel fragment types.
Results
Identiﬁcation of the genotypes of the HBV sequences
In our dataset, there were 3471 HBV sequences (Fig. 1), of which
3403 sequences were isolated from humans, taking up 98% of the
total. Three sequences were isolated from woolly monkeys. They
were always clustered together and were used as an outgroup in
the phylogenetic analyses. The remaining 65 sequences were isolated
from other primates, such as chimpanzees, gorillas, orangutans and
gibbons. In addition, 315 out of the 3403 sequences did not have ge-
notype information available in GenBank or haven't been analyzed
and published (Table S1).
Based on the background information extracted from GenBank
and the references, the genotype of the sequences from humans
was deﬁned using the phylogenetic tree obtained from complete ge-
nome sequences. A sequence divergence of 8% was also used to distin-
guish different genotypes (Table 1). For the 315 sequences without
genotype information available, theywere identiﬁed to be of genotypes
A (n=35, 11.1%), B (n=74, 23.5%), C (n=137, 43.5%), D (n=51,
16.2%), F (n=1, 0.3%), G (n=6, 1.9%) andH (n=11, 3.5%) respectively.
In addition, there were 63 sequences whose genotype information was
inaccurate and this data was summarized in Table S2.
Overall, 418 sequences (12.3% of total) were identiﬁed to be of ge-
notype A and 860 sequences (25.3%) were found to belong to geno-
type B (Fig. 2). The numbers of sequences of genotypes C to I were
1214 (35.7%), 460 (13.5%), 221 (6.5%), 96 (2.8%), 28 (0.8%), 30
(0.9%) and 51 (1.5%), respectively (Fig. 2). Only one sequence
(AB486012, 0.03%) belonged to genotype J (Tatematsu et al., 2009).
Sequence divergence between any two of the above genotypes was
always greater than 8%, with the exception of genotype I (Table 1).
However, between genotypes B and C, there were 24 sequences
from China that had less than 8% sequence divergence with both ge-
notypes B and C (Fig. 2 and Table 1). These sequences were provision-
ally assigned as genotype “BC”.
Identiﬁcation of putative inter-genotypic recombinants
We further analyzed the genotypes of the sequences using phylo-
genetic trees obtained from 13 sub-genomic fragments derived from
the complete genome dataset with each strain thus having 13 geno-
type tags. If all of the genotypes of sub-genomic fragments are in
agreement with the whole alignment analysis, this sequence was
considered unlikely to be a recombinant and was not analyzedFig. 1. The HBV sequences analyzed in this study. The axis gives the numbers of HBV
sequences in log scale.further. Alternatively, if a discrepancy was identiﬁed between the
whole genome and sub-genomic phylogenies, then we assigned the
sequence as a putative inter-genotypic recombinant. Employing this
experimental strategy, we found that 1047 out of 3403 (30.8%) se-
quences were putative recombinants (Fig. 3). 803 out of 860 geno-
type B viruses were identiﬁed to be possible recombinants which
may be due to co-infection with genotype C in Asia where both geno-
types are prevalent (Sakamoto et al., 2007; Sugauchi et al., 2002). In
addition, all putative genotype I viruses and the previously described
genotype “BC” viruses were also recombinants.
After excluding the recombinants that were previously reported
(n=280), we have 767 sequences. Among them, 653 sequences
belonged to the fragment type “BBBBBBBCCBBBB” in which the recom-
bination occurred at the preC-C region. In fact, this recombination type
has been widely recognized (Sugauchi et al., 2002; Yang et al., 2006)
and therefore these viruses were not regarded as novel recombinants.
However, the remaining 114 sequences are recombinants identiﬁed
for the ﬁrst time and are summarized in Table 2. It should be noted
that the fragment types of IG-3, IG-32 and IG-33 have already been
reported (Yang et al., 2006) and were not studied in our subsequent
analysis.
Further veriﬁcation of the putative recombinants
The putative recombinants were further analyzed by a series of
methods (Table 3). For 31 out of the 41 putative fragment types, at
least one method gave evidence of recombination. In particular, four
or ﬁve methods gave evidence of recombination for 22 putative
recombinants. However, none of the ﬁve methods gave evidence of
recombination for 10 putative fragment types (IG-2, IG-5, IG-28, IG-
31, IG-35, IG-38, IG-39, IG-41, IG-42 and IG-43) and these were ex-
cluded. Viruses belonging to these fragment types (n=42) were
regarded as suspect recombinants.
Identiﬁcation of the breakpoints for the putative recombinants
For the putative recombinants veriﬁed by other programs,we deter-
mined the breakpoints using Simplot by maximizing χ2 value and con-
sidering the transition of the similarity curves of the two parental
genotypes (Table 4). However, we did not obtain the maximum values
of χ2 in two cases, the tenth segments of IG-23 and IG-24 from geno-
type B (Table 4). Therefore, we concluded that IG-23 was a B/C recom-
binant with the recombination type “CCBCCCCCCCCCC” and IG-24 was
not a triple recombinant but a C/A recombinant.
We mapped the breakpoints of the novel recombinant sequences
(n=72) onto the HBV genome (Fig. 4) and found most of them
were located at or near the gene boundaries (Sugauchi et al., 2002;
Yang et al., 2006). In particular, genotype C viruses tend to recombine
within the preC-C region in other genotypes, especially genotype B
(Yang et al., 2006). However, the novel recombinants had different
breakpoints with the widely circulating B/C recombinants (Sugauchi
et al., 2002; Yang et al., 2006). We also found that a few genotype C
viruses recombine their S region to genotype B viruses, such as IG-
11 to IG-15 (Fig. 4). At the same time, the reverse recombination of
the S region from genotype B to genotype C was also observed in
IG-20 to IG-23 (Fig. 4).
Description of the recombinants identiﬁed in this study
Overall, 72 recombinant sequences were described here for the
ﬁrst time and were also supported by independent analysis as novel
recombinants. 42 sequences were regarded as suspect recombinants
due to a lower level of support obtained from different methods.
These 72 novel recombinants belonged to 34 fragment types and
three of them, IG-3, IG-32 and IG-33, have been reported already.
Table 1
Mean percentage of nucleotide sequence divergence between HBV complete genomes from genotypes A to J and tentative BC*.
A B BC C D E F G H I J Monkey
A 0.6 0.6 0.6 0.5 0.6 0.8 0.6 0.8 0.5 0.8 1.4
B 10.8 0.3 0.5 0.6 0.6 0.8 0.7 0.8 0.5 0.7 1.5
BC 11.4 6.1 0.4 0.7 0.6 0.8 0.7 0.8 0.6 0.7 1.5
C 10.3 10.0 6.5 0.7 0.6 0.8 0.7 0.8 0.4 0.7 1.5
D 11.4 12.5 12.3 11.8 0.5 0.8 0.6 0.8 0.6 0.7 1.5
E 11.8 13.3 12.9 12.5 8.8 0.7 0.6 0.8 0.6 0.7 1.5
F 17.3 17.3 17.5 16.8 17.2 17.3 0.9 0.5 0.8 0.8 1.6
G 13.2 15.0 15.4 14.7 13.4 12.6 18.2 0.9 0.7 0.8 1.4
H 17.4 17.7 18.1 17.1 17.1 17.8 9.2 18.5 0.8 0.9 1.7
I 9.1 10.1 10.2 8.0 11.6 12.1 16.9 13.0 17.1 0.7 1.7
J 14.1 12.7 12.8 12.8 14.7 14.0 17.5 15.2 17.6 12.9 1.6
Monkey 31.4 30.8 30.7 30.9 31.4 31.5 33.6 32.1 34.3 32.0 33.2
The lower left triangle includes the mean percentage of nucleotide sequence divergence between HBV complete genomes from genotypes A to J and tentative BC. The upper right
triangle includes the corresponding standard deviations of the mean values.
53W. Shi et al. / Virology 427 (2012) 51–59A/C recombinants
A/C recombinants included three inter-genotype fragment types,
IG-1, IG-24 and IG-26. The sequence of IG-1 was isolated from SouthFig. 2. Phylogenetic analysis of the 3471 HBV genomes. Different colors indicate differ-
ent genotypes. The number following the genotype indicates the number of sequences
belonging to this genotype.Africa and belonged to genotype A, while those of IG-24 and IG-26
were isolated from Taiwan, with the genotype C.
A/D recombinants
There were three kinds of A/D recombinants, IG-3, IG-36 and IG-37.
The sequence of IG-3 was from Poland and belonged to genotype A,
while those of IG-36 and IG-37 belonged to genotype D, isolated from
Uzbekistan and Tunisia respectively. Although the sequence of IG-3
was reported to be a recombinant for the ﬁrst time, sequences sharing
this fragment type have been previously reported (Yang et al., 2006).
A/G recombinant
A single sequence was determined to be an A/G recombinant, with
the fragment type AAGGGGGGGGGGG (IG-44). This sequence,
EF464099, was isolated from Brazil and the possibility that this ge-
nome represented a recombinant was already reported (Bottecchia
et al., 2008). In this study, we found three of the ﬁve methods to sup-
port its designation as an A/G recombinant.
B/C recombinants
Recombination between genotypes B and C has been reported to
be prevalent in Asia (Sakamoto et al., 2007; Sugauchi et al., 2002).
Apart from the dominant fragment type “BBBBBBBCCBBBB” which
653 sequences possessed, there were 23 different inter-genotype
fragment types, comprising 53 sequences. All these BC recombinants
were isolated from Asia, largely from China. Among them, viruses of
11 inter-genotype fragment types (IG-4, IG-6 to IG-15) belonged toFig. 3. Numbers of HBV recombinants and non-recombinants among different
genotypes.
Table 2
Inter-genotype recombination of the 114 putative recombinants identiﬁed in this analysis.
Fragment type IG⁎ Genotype No. Country Accession no. References⁎⁎
AAAAAAACAAAAA IG-
1
A 1 South Africa AY233277 Kimbi et al. (2004)c
AAAAAAADAAAAA IG-
2
A 11 Italy, Belgium, Poland, Tunisia,
Japan, France, Cameroon
AB453985, AF090838, DQ298161–DQ298165,
EU859938, FJ904411, FN545837, GQ477473
Stuyver et al. (1999)c, Matsuura et al.
(2009))c, Meldal et al. (2009)c,
Pourkarim et al. (2009)c, Grabarczyk
et al. (2010)c, Hubschen et al. (2011)d
AAAAAADAAAAAA IG-
3
A 1 Poland GQ477479 Simmonds and Midgley (2005)a,
Yang et al. (2006)a
BBBBBBBBCBBBB IG-
4
B 1 Malaysia GQ924624 Yang et al. (2006)b
BBBBBBBCBBBBB IG-
5
B 7 Japan AB073853, AB073855, AB073858, AB106885,
AB205121, AB287327, AB300371
BBBBBBBCCCBBB IG-
6
B 2 Indonesia AB493827, AP011094 Lusida et al. (2008)c, Mulyanto et al.
(2009)c, Utsumi et al. (2009)c,
Yang et al. (2006)b
BBBBBBCCCBBBB IG-
7
B 1 China EU158262
BBBBBCCCCBBBB IG-
8
B 1 China EU939627
BBBBCBBCCCCCB IG-
9
B 1 Taiwan EU660227
BBBBCCBCCBBBB IG-
10
B 1 China GQ377595 Xu et al. (2010)c
BBCBBBBCCBBBB IG-
11
B 1 China FJ386648
BBCCBBBCCBBBB IG-
12
B 1 China FJ386674
BCBBBBBCCBBBB IG-
13
B 2 China, Indonesia EU939634, AB493831 Mulyanto et al. (2009)c
BCCBBBBCCBBBB IG-
14
B 1 China HQ684848
BCCCXBCCCBBBB IG-
15
B 1 China GQ377592
BCCCCCCCCBBBB IG-
16
BC 16 China EU939620, EU939621, EU939623, EU939630,
EU939632, FJ562247, FJ562328, GQ377549,
GQ377564, GQ377573, GQ377596, GQ377604,
GQ377613, GQ377614, GQ377626, GQ377634
CCCCCCCCCBBBB IG-
17
BC 8 China EU939622, FJ562229, GQ377539, GQ377556,
GQ377565, GQ377590, GQ377594, GQ377602
BBBBBBBCCCCCC IG-
18
C 1 China EU939629
CBBBBBBCCCCCC IG-
19
C 4 China EU939628, EU939631, GQ377630, GQ377635
CBCCCBBCCCCCC IG-
20
C 1 China HQ684849
CBCCCCCCCCCCC IG-
21
C 1 China GU357843
CCBBCCCCCCCCC IG-
22
C 1 Taiwan EU882006
CCBCCCCCCBCCC IG-
23
C 1 Philippines AB241109 Sakamoto et al. (2006)d
CCCAAAAACBCCC IG-
24
C 1 Taiwan EF494378 Shih et al. (2008)c
CCCBBBBCCCCCC IG-
25
C 1 China FJ386646
CCCCCCCAAAACC IG-
26
C 1 Taiwan EF494376 Shih et al. (2008)c
CCCCCCCCCBBCC IG-
27
C 1 China FJ032343
CCCCCCCCCBCCC IG-
28
C 15 Viet Nam, Malaysia, Indonesia,
Philippines, China
AB241110, AB241111, AF241410, AF241411,
AP011099, AP011100, AP011101, EU410079,
EU410080, EU410081, FJ032337, GQ924620,
GQ924622, GQ924657, Y18858
Sakamoto et al. (2006)d, Hannoun et al.
(2000)c, Cavinta et al. (2009)c, Mulyanto
et al. (2009)c, Meldal et al. (2011)c
CCCCCCCCCCBBC IG-
29
C 1 China EU796069
CCCCCCCCCCCCB IG-
30
C 4 Taiwan EU522070, EU660228, EU881995, EU919166
CCCCCCC(D/E)
CCCCC
IG-
31
C 1 China GQ377599
DDDCCCCCCCCCC IG-
32
C 6 China EU678470–EU678472, EU678474, EU678475,
FJ562278
Yang et al. (2006)a
DDDDDDCCCCCCC IG-
33
C 2 China EU678473, FJ562263 Yang et al. (2006)a
DCCCCCCDDDDDD IG-
34
D 3 China FJ562223, GQ377532, GQ377627
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Table 2 (continued)
Fragment type IG⁎ Genotype No. Country Accession no. References⁎⁎
DCDDDDDDDDDDD IG-
35
D 1 Japan AB210818
DDDADDDDDDDDD IG-
36
D 1 Uzbekistan AB188244 Michitaka et al. (2007)c
DDDDDDDADDDDD IG-
37
D 1 Tunisia FJ904409 Meldal et al. (2009)b
DDDDDDDBDDDDD IG-
38
D 1 Mongolia DQ111986 Odgerel et al. (2006)c
DDDDDDDCDDDDD IG-
39
D 1 Iran GU456667 Garmiri et al. (2011)c
DDDDDDDDDDDDC IG-
40
D 1 China FJ562309
DDEDDDDDDDDDD IG-
41
D 1 Belarus EU414140 Olinger et al. (2008b)d
EEEEEECEEEEEE IG-
42
E 2 Nigeria HM363600, HM363607 Forbi et al. (2010)c
FFFFFFFCFFFFF IG-
43
F 2 Argentina, Bolivia AB365453, DQ823087 Khan et al. (2008)c, Torres et al. (2011)e
AAGGGGGGGGGGG IG-
44
G 1 Brazil EF464099 Bottecchia et al. (2008)e
⁎ IG means inter-genotype recombination.
⁎⁎ Different letters following the references have different meanings. An “a” means that this recombination event has been found in other sequences, but this sequence has not
been reported to be a recombinant. A “b” means that these sequences have been reported to be recombinants, but our results gave different recombination events. A “c” means
that these sequences haven't been reported to be recombinants. A “d” means that these sequences have been reported not to be recombinants. An “e” means that the original ref-
erences did not exclude the possibility of these sequences to be recombinants, but they did not give a deﬁnite result.
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belonged to genotype C.
In particular, viruses of IG-16 and IG-17, which were provisionally
deﬁned as genotype BC, were all B/C recombinants. 16 sequences of
IG-16 possessed the fragment type BCCCCCCCCBBBB, while 8 sequences
of IG-17 possessed CCCCCCCCCBBBB.
In addition, sequences of IG-4 (BBBBBBBBCBBBB), IG-6 (BBBBBBB
CCCBBB) and BBBBBBBCCBBBB, designated here, have been previously
analyzed and been assigned the same fragment type (BBBBBBBCCNBBB)
in a previous studywith numerous B/C recombinants (Yang et al., 2006).
C/D recombinants
Four C/D fragment types were identiﬁed. IG-32 and IG-33
belonged to genotype C and both of them have been reported
before (Yang et al., 2006). Eight viruses of these two recombination
types were all isolated from China. The other two recombination
types, IG-34 and IG-40, were genotype D, and viruses belonging to
these recombination types were also isolated from China.
Discussion
Recombination is a very important mechanism for HBV genome
evolution and variation. There have been a number of studies regard-
ing HBV recombination. Three of them were relatively large scale,
with each analyzing a few hundred HBV genome sequences available
from public databases and describing some novel HBV recombinants
(Simmonds and Midgley, 2005; Yang et al., 2006; Ye et al., 2010).
However, there remain many HBV genome sequences that haven't
undergone recombination analysis. To identify potential HBV recom-
binants, we analyzed approximately 3400 HBV nearly full-length ge-
nome sequences by phylogenetic analysis. Strikingly, our results
showed that 1047 sequences had evidence of recombination and 72
sequences were identiﬁed to be recombinants for the ﬁrst time.
803 out of 860 genotype B sequences were identiﬁed to be B/C
recombinants. This is consistent with the previous report that viruses
from Japan of subgenotype Bj are non-recombinants, while viruses
belonging to other genotype B subtypes are recombinants (Sugauchi
et al., 2002). Genotype B viruses isolated from Canada (Osiowy et
al., 2006) and Greenland (Sakamoto et al., 2007) are also non-
recombinants. Although most of the B/C recombinants are genotypeB, they belong to different fragment types, with different breakpoints,
such as IG-7 to IG-10. Similarly, the B/C recombinants of genotype C
and C/D recombinants of genotype D have also been identiﬁed to be-
long to several different fragment types, with different breakpoints.
Therefore, generally nominating them as B/C and C/D recombinants
will neglect the chimerical nature of these viruses and the differences
between them. It is recommended that recombinants should be
reported individually (Pourkarim et al., 2010), however, there are
not generally accepted rules for reporting HBV recombinants.
In particular, recombination between genotypes B and C gave rise
to 24 viruses that have a sequence divergence of less than 8% from
both genotypes B and C. In fact, apart from these 24 viruses, all
other recombinants can be classiﬁed into a speciﬁc genotype, from
the known and putative genotypes A to I. However, in this case, be-
cause it breaks the accepted threshold of sequence divergence of
8%, we could not deﬁne a genotype for them, but name them geno-
type “BC”. This poses a challenge to the current HBV nomenclature
system.
Several single or double mutations have been reported to be asso-
ciated with increased viral replication capacity or enhanced drug re-
sistance. For example, mutations T1753V (C/A/G), C1766T, T1768A,
G1862T and G1899A in the basal core promoter and precore regions
have been related to increased HBV replication capacity and/or re-
duced HBeAg expression in vitro, in vivo and in some cases associated
with ALF in the clinic (Baumert et al., 1996; Hou et al., 2002; Ren et al.,
2010; Sainokami et al., 2007;Wai et al., 2005). In addition, amino acid
positions at 80, 173, 180, 181, 184, 202, 204, 236 and 250 in the
reverse-transcriptase protein were reported to inﬂuence drug resis-
tance of the viruses (Xu et al., 2010). The recombined segments of
the newly identiﬁed recombinants in this work, such as IG-9 and
IG-10, covered the above regions. Therefore, recombination between
different genotypes might have clinical signiﬁcance (Zeng et al.,
2005) and this deserves further investigation.
Regarding the hot spots of the novel HBV recombinants, we found
that most of the breakpoints are located at or near the gene bound-
aries, such as the start of the P and the end of the X gene, in agree-
ment with previous reports (Simmonds and Midgley, 2005; Yang et
al., 2006). Previous studies have shown that a certain region of one
genotype tends to be integrated into other genotypes (Yang et al.,
2006). Some of the novel recombinants also showed this pattern,
for example, genotype C viruses are prone to contribute the preC-C
Table 3
Veriﬁcation of the putative HBV recombinants by RDP, BootScan, MaxChi, Chimaera and 3Seq.
IG Recombinant Representative RDP BootScan MaxChi Chimaera 3Seq
IG-1 A/C AY233277 × Yes × × ×
IG-2 A/D AB453985 × × × × ×
IG-4 B/C GQ924624 Yes Yes Yes Yes Yes
IG-5 B/C AB073853 × × × × ×
IG-6 B/C AB493827 Yes Yes Yes Yes o
IG-7 B/C EU158262 Yes Yes Yes × Yes
IG-8 B/C EU939627 Yes Yes Yes Yes Yes
IG-9 B/C EU660227 Yes Yes Yes Yes Yes
IG-10 B/C GQ377595 Yes Yes Yes Yes Yes
IG-11 B/C FJ386648 Yes Yes Yes Yes Yes
IG-12 B/C FJ386674 Yes Yes Yes Yes Yes
IG-13 B/C EU939634 Yes Yes Yes Yes Yes
IG-14 B/C HQ684848 Yes Yes Yes Yes Yes
IG-15 B/C GQ377592 Yes Yes Yes Yes Yes
IG-16 B/C EU939620 Yes Yes Yes Yes Yes
IG-17 B/C EU939622 Yes Yes Yes Yes Yes
IG-18 B/C EU939629 Yes Yes Yes Yes Yes
IG-19 B/C EU939628 Yes Yes Yes Yes Yes
IG-20 B/C HQ684849 Yes Yes Yes Yes Yes
IG-21 B/C GU357843 × Yes × × Yes
IG-22 B/C EU882006 × Yes Yes × Yes
IG-23 B/C AB241109 × Yes × × Yes
IG-24 C/A/B EF494378 Yes Yes Yes Yes Yes
IG-25 B/C FJ386646 × Yes Yes Yes Yes
IG-26 A/C EF494376 Yes Yes Yes Yes Yes
IG-27 B/C FJ032343 × Yes × × ×
IG-28 B/C AB241110 × × × × ×
IG-29 B/C EU796069 × Yes × × ×
IG-30 B/C EU522070 × Yes Yes Yes Yes
IG-31 C/(D/E) GQ377599 × × × × ×
IG-34 C/D FJ562223 Yes Yes Yes Yes Yes
IG-35 C/D AB210818 × × × × ×
IG-36 A/D AB188244 × Yes × × Yes
IG-37 A/D FJ904409 × × × × Yes
IG-38 B/D DQ111986 × × × × ×
IG-39 C/D GU456667 × × × × ×
IG-40 C/D FJ562309 × Yes Yes Yes Yes
IG-41 D/E EU414140 × × × × ×
IG-42 C/E HM363600 × × × × ×
IG-43 C/F AB365453 × × × × ×
IG-44 A/G EF464099 × Yes o Yes Yes
“×” means no evidence of recombination is found, while “Yes” indicates that evidence of recombination is found. “o” indicates a run-time error and the program did not ﬁnish the
run.
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viruses possess the S region of genotype B origin and vice versa.
There are a number of methods to detect potential recombination
events, such as RDP, BootScan, MaxChi, Chimaera and 3Seq, which
were used in this analysis. The performance of 14 different recombi-
nation detection programs, has been previously evaluated by both
computer simulations (Posada and Crandall, 2001) and empirical
datasets (Posada, 2002), three of which (RDP, BootScan and MaxChi)
were used for veriﬁcation of the putative HBV recombinants identi-
ﬁed by our phylogenetic analysis. Results obtained using empirical
data were previously found to be broadly in agreement with those
from computer simulations. However, individual programs had dis-
tinct performance proﬁles depending on the size of the recombina-
tion event, overall genetic diversity, and rate of variation between
sites. Our data support these trends (Table 3). For example, RDP
showed positive evidence of recombination for 19 out of 41 fragment
types, while BootScan supported 30 out of 41 fragment types, with
the numbers of veriﬁed fragment types by MaxChi, Chimaera and
3Seq being 23, 22 and 27, respectively. BootScan is phylogeny-based
(Posada and Crandall, 2001) and that may well account for why it
showed more agreement with the phylogenetic analyses and gave
the highest number of veriﬁed recombinants. However, RDP is also
phylogeny-based (Posada and Crandall, 2001), but showed the least
agreement with the results obtained from phylogenetic analyses.
Generally, the recombinants veriﬁed by RDP were also supported byother methods (Table 3). Among the 19 fragment types veriﬁed by
RDP, 17 were also supported by the four other methods listed above
and two were supported by three of the other methods. The putative
HBV recombinants IG-22, IG-30, IG-40 and IG-44 were well supported
by at least three methods, however, RDP did not show evidence of re-
combination (Table 3). As other authors have noted, it is recom-
mended to try different methods to detect recombination events in
order to derive deﬁnitive conclusions (Posada, 2002).
However, the aforementioned computer programs have problems
to analyze our dataset due to heavy computational requirements. In
order to use them to verify the results obtained from phylogenetic
analysis and to reduce the computational load, we composed smaller
datasets, which each including just four sequences. Two of themwere
the consensus sequences from the two parental genotypes. Because
the potential real parents of the recombinants were not identiﬁed,
this might reduce the sensitivity of the methods used for veriﬁcation.
Therefore, the possibility of those 42 suspect recombinants that did
not have well supported evidence of recombination by our analysis
to be recombinants cannot be fully excluded and deserves further
study.
In conclusion, 1047 out of 3403 sequences were identiﬁed to be
recombinants, 72 of which were novel recombinants identiﬁed for
the ﬁrst time and 42 of which were suspect recombinants. These 72
novel recombinants belonged to 34 fragment types, 31 of which
were reported for the ﬁrst time. In addition, we reported 24 B/C
Table 4
Identiﬁcation of the breakpoints for the putative HBV recombinants using Simplot.
No. IG G1 G2 Representative Fragment Length
(bp)
Identity (%)b Location⁎
G1 G2
1 IG-1 A C AY233277 1730–1934 205 91.2 93.6 Xend-Cstart
2 IG-4 B C GQ924624 1859–2294 436 76.3 87.6 preC-C/Pstart
3 IG-6 B C AB493827 1832–2401 570 79.2 89.1 preC-Cend
4 IG-7 B C EU158262 1661–2267 607 80.8 88.3 X/Pend-C/Pstart
5 IG-8 B C EU939627 1229–2274 1046 83.4 90.0 P-C/Pstart
6 IG-9 B C EU660227 1089–1259 171 85.3 90.0 P-P
B C 1862–2876 1015 80.0 89.2 preC-preS1start/P
7 IG-10 B C GQ377595 1073–1580 508 85.4 90.1 P-X/Pend
B C 1764–2274 511 79.8 89.8 X-C
8 IG-11 B C FJ386648 440–658 219 93.1 93.1 S-S
B C 1657–2272 616 80.6 88.4 X/Pend-C/Pstart
9 IG-12 B C FJ386674 493–1068 576 86.2 88.3 S-P
B C 1873–2188 316 72.7 85.1 preCend-C
10 IG-13 B C EU939634 225–482 258 89.1 95.3 S-S
B C 1842–2256 415 76.3 87.7 preC/Xend-C/Pstart
11 IG-14 B C HQ684848 224–635 412 90.0 95.1 S-S
B C 1842–2266 425 77.1 88.2 preC/Xend-C/Pstart
12 IG-15 B C GQ377592 282–1051 770 86.3 89.3 S-P
B C 1565–2253 689 81.4 89.4 X/Pend-C/Pstart
13 IG-16 C B EU939620 2268–224 1170 84.7 86.6 C/Pstart-S
14 IG-17 C B EU939622 2276–3213 938 82.9 84.0 C/Pstart-preS1end
15 IG-18 B C EU939629 1729–3213 1485 81.5 90.8 X-preS1end
16 IG-19 C B EU939628 255–1741 1487 87.4 89.5 S-X
17 IG-20 C B HQ684849 126–598 473 91.3 92.6 preS2end-S
C B 1272–1829 558 88.1 89.9 P-Xend/preC
18 IG-21 C B GU357843 164–388 225 90.2 90.2 Sstart-S
19 IG-22 C B EU882006 388–886 499 90.3 92.7 S-P
20 IG-23 C B AB241109 526–833 308 93.1 94.8 S-Send
C B AB241109a
21 IG-24 C A EF494378 661–1831 1171 87.0 91.8 S-Xend/preC
C B EF494378a
22 IG-25 C B FJ386646 780–1832 1053 86.1 87.1 S-Xend/preC
23 IG-26 C A EF494376 1881–2775 895 83.0 88.1 preC-P
24 IG-27 C B FJ032343 2200–2681 482 87.5 84.8 C-P
25 IG-29 C B EU796069 2510–2773 264 78.4 78.7 P-P
26 IG-30 C B EU522070 2842–3213 372 85.4 87.0 preS1start-preS1end
27 IG-34 D C FJ562223 194–1702 1509 86.0 90.9 Sstart-X
28 IG-36 D A AB188244 641–926 286 86.7 91.6 S-P
29 IG-37 D A FJ904409 1730–1944 215 89.7 92.5 X-Cstart
30 IG-40 D C FJ562309 3058–3225 168 79.1 91.6 preS1-preS1end
31 IG-44 G A EF464099 1–392 392 90.3 93.1 preS2start-S
a The maximum values of χ2 were not obtained around the putative recombined fragments.
b The identity was estimated using the consensus sequences of the non-recombinants of different genotypes.
⁎ We just list the genes where the breakpoints are located.
Fig. 4. Distribution of the breakpoints of the novel recombinants. The recombined regions of the 31 fragment types are marked up onto an HBV genome using different colors
according to their identiﬁed breakpoints. The non-recombined regions are not shown.
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58 W. Shi et al. / Virology 427 (2012) 51–59recombinants that showed sequence divergence less than 8% with
both genotypes B and C, which poses a challenge to the current HBV
nomenclature system.
Materials and methods
Nucleotide sequences of HBVwere downloaded fromGenBankat the
National Center for Biotechnology Information (GenBank ID: BA123456)
using Hepatitis B virus as the search query on 18th February, 2011. The
full length HBV genome is approximately 3200 bp in size. Sequences
shorter than 3050 bp and those with more than 30 unknown nucleo-
tides were removed from the dataset, leaving 3471 sequences to be an-
alyzed. Information on these sequences, such as genotype, subgenotype,
and recombination, was also extracted from existing GenBank annota-
tions. For sequences with an associated citation in PubMed, genotype
and recombination information was obtained to assist deﬁning geno-
types, subgenotypes and novel recombinants. The list of the sequences
and corresponding background information is available as supplemen-
tary Table S1.
A multiple alignment of the sequences was made using Muscle
(Edgar, 2004) and then adjusted manually in Bioedit (Hall, 1999).
Then the alignment was subdivided into 13 sub-datasets, each con-
sists of a section 250 bp long (the last was 267 bp long). The number-
ing starts at the hypothetical EcoRI site. The subdivision of the whole
HBV genome into 13 sub-datasets was previously named “fragment
typing” to identify putative HBV recombinants (Yang et al., 2006).
In this report, we continued to use this deﬁnition although our meth-
od was not exactly the same as that Yang et al. (2006) used. Phyloge-
netic analysis of the whole genome alignment and 13 sub-datasets
was carried out using RAxML (Stamatakis et al., 2005) under the
GTRCAT approximation (Stamatakis, 2006) and random starting
trees. Four thousand rapid bootstrap replicates were performed and
all other parameters were set to default. These trees are available as
supplementary ﬁle S2. Trees were visualized using Dendroscope
(Huson et al., 2007). The three sequences fromwoolly monkeys always
clustered together and were employed as an outgroup (Simmonds and
Midgley, 2005).
The genotype for each full length sequence was identiﬁed using
the phylogenetic tree constructed from the whole genome sequences
and this was used as background information. The mean nucleotide
divergence (mean±SD) between different genotypes was calculated
using Mega 5 (Tamura et al., 2011) using the Kimura 2-parameter
model (Kimura, 1980). Genotyping information from each phyloge-
netic tree constructed using the 13 sub-datasets was compared to
the background information, one by one. For each sequence, if all
the information was concordant with the background information,
this suggested that the virus was not a recombinant, however, if a dis-
crepancy between whole alignment genotyping and genotypes de-
rived from the sub-datasets was identiﬁed, these sequences were
parsed for further analysis by the multiple, independent computa-
tional methods described below.
These putative recombinants were analyzed further by RDP
(Martin et al., 2005), BootScan (Martin et al., 2005), MaxChi (Smith,
1992), Chimaera (Posada and Crandall, 2001) and 3Seq (Boni et al.,
2007) respectively, all of which are embedded in the program RDP
(Martin et al., 2010). However, to reduce the computational cost,
we generated smaller datasets for the putative recombinants, each in-
cluding four sequences. The ﬁrst sequence in each dataset was the pu-
tative recombinant, the second and third sequences were consensus
sequences created for each parental genotype using the sequences
that did not give recombination signals in the previous step, and ﬁnal-
ly the fourth sequence was from the woolly monkey (NC_001896)
outgroup. In these analyses, all the parameters were set to default.
Simplot was used to deﬁne the locations of the breakpoints for the
putative recombinants (Lole et al., 1999) using the same datasets
used in the previous step. The breakpoints were chosen based onthe following rules. Firstly, the designation of the breakpoints should
maximize the χ2. Secondly, the breakpoints should match transitions
in the similarity curves calculated by Simplot using the two parental
genotypes.
Conclusions
In this report, we analyzed 3403 full-length HBV genome sequences
isolated from humans to identify putative recombinants using phyloge-
netic analysis. Our results showed that 3379 out of 3403 sequences
belonged to the known and putative genotypes A to J, with 315 se-
quences deﬁned in this analysis. The remaining24 viruses had sequence
divergence of less than 8% from both genotypes B and C and were pro-
visionally assigned genotype “BC”. 1047 out of 3403 sequences were
identiﬁed to be putative recombinants, of which 72 were identiﬁed to
be novel recombinants. Notably, all viruses of the herein described ge-
notype “BC”were identiﬁed to be B/C recombinants.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.virol.2012.01.030.
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